Literature DB >> 25799802

Cystoscopic bladder biopsies: a histopathological study.

S Pudasaini, N Subedi, K B R Prasad, S K Rauniyar, B R Joshi, K K Bhomi.   

Abstract

Urothelial carcinoma is the most common tumor of the bladder and is a major cause of morbidity and mortality. Cystitis constitutes an important source of clinical signs and symptoms. In this study 31 cystoscopic biopsies subjected for histopathological examination were taken. The study was conducted in the department of Pathology of Nepal Medial College Teaching Hospital over a period of two years (October 2012 to September 2014). The mean age of the patient undergoing cystoscopic biopsy was 61.3 years, most of the patients being elderly male. 51.6% cases were clinically malignant. The most common histopathological diagnoses were cystitis (29%) and non invasive papillary urothelial carcinoma, low grade (29%). 58% are neoplastic lesions. 51.6% of the case was malignant lesions on histopathology. Among the malignant lesion of urinary bladder 93.7% were urothelial tumor and 6.3% were glandular neoplasm (adenocarcinoma, signet ring cell). There was no detrusor muscle in 33.3% cases of urothelial tumor to assess the muscle invasion. 26.7% cases of urothelial tumor shows muscle invasion. Histopathological study of cystoscopic biopsy helps in early detection of tumor and its management.

Entities:  

Mesh:

Year:  2014        PMID: 25799802

Source DB:  PubMed          Journal:  Nepal Med Coll J


  3 in total

1.  Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer.

Authors:  Liqing Zhang; Xiuxia Guo; Yongzheng Min; Jianjiang Xu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.

Authors:  Jehn-Hwa Kuo; An-Cheng Huang; Jen-Jyh Lin; Kuang-Chi Lai; Rick Sai-Chuen Wu; Jiun-Long Yang; Bin-Chuan Ji; Mei-Due Yang; Yung-Lin Chu; Jing-Gung Chung
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

3.  Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients.

Authors:  Jianlei Lu; Feng Zhong; Beibei Sun; Chao Wang
Journal:  Med Sci Monit       Date:  2019-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.